The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place.
Government is expanding prescription coverage for long-acting muscarinic antagonist (LAMAs) inhalers, used in the treatment of Chronic Obstructive Pulmonary Disease. The change to open listing on the NL Prescription Drug Program reduces the administrative burden of prescribers by eliminating the special authorization process that had been in place. This will ensure NLPDP beneficiaries have timely access to these inhalers for the treatment of their COPD.
78-year-old McIvers man appears in court charged with attempted murder
RCMP seizes a vehicle in Deer Lake on Wednesday, speeding, erratic driving and no insurance
78-year-old man charged with attempted murder after shooting incident in McIvers yesterday
Minimum wage in NL going up by $0.35 on April 1st
